Joshua S. Prince - 31 Dec 2025 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Operating Officer
Signature
Joshua Prince
Issuer symbol
VTGN
Transactions as of
31 Dec 2025
Net transactions value
+$2,468
Form type
4
Filing time
05 Jan 2026, 20:51:53 UTC
Previous filing
01 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Prince Joshua S. Chief Operating Officer C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVE, SOUTH SAN FRANCISCO Joshua Prince 05 Jan 2026 0001998663

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $2,468 +4,386 +40% $0.5626 15,249 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).